Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT02249793
Collaborator
Ginger.io (Industry)
6
1
39
0.2

Study Details

Study Description

Brief Summary

As citizens of the information age, humans leave digital traces of behavior in their communication and movement patterns through our cell phone. The Global Positioning System (GPS) technology tracks the way persons commute to school or work or when visiting family and friends. Circadian rhythmicity describes the concept that many of the bodily functions follow a roughly 24-hour rhythm. Usually, the ability to do concentrated and focused work is best during daytime while humans rest and sleep during nighttime. The current study wishes to look for a relationship between patterns in participants' cell phone use (Android only at this point) and several of their bodily functions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Cell phones with internet access (so-called smartphones) represent a rich source for user activity data. Each time one places a call, sends a text message, or uses an app, a data trace is being produced which overall reflects the user's social activity and behavior. This data is called 'social sensing data'. Researchers connected this type of data to the health status of the person operating the cell phone. An example is that an outbreak of seasonal flu may lead to fewer calls and text messages among cell phone users. Thus, the social sensing data may show for example how severe an outbreak is and how fast it is spreading.

    "Circadian rhythmicity" describes the concept that many of the bodily functions follow a roughly 24-hour rhythm. Usually, the ability to do concentrated and focused work is best during daytime while rest and sleep occurs during nighttime. A disturbance of this pattern, for example by regular nightshift work, may lead to an increased disease risk, such as for the cardiovascular system, the heart and blood vessels. Natural factors within a body produce our 24-hour rhythm. This rhythm is affected by outside cues such as sunlight. Jet lag is a short-term form of a disturbed 24-hour rhythm. When a person travels fast through several time zones, by plane for example from the East to the West Coast of the US, s/he arrives with a time difference of 3 hours. Upon arrival, the body runs still at East Coast time, but is exposed to the environmental cues following the West Coast time, which may make the person feel groggy and disoriented at first. Within a couple of days the body time usually adjusts and the complaints discontinue.

    The current study wishes to look for a relationship between patterns in the participant's cell phone use (Android only at this point) and several of the bodily functions. As bodily functions the investigators will measure blood pressure and breakdown products (metabolites) in urine, blood and saliva samples. The investigators will collect stool samples and use swabs to collect the microbes inhabiting the mouth as well as the rectum. The investigators will also measure messenger ribonucleic acid (mRNA), messenger products of the participant's heritable information, in the blood. A cell phone application called "Ginger.io" will collect the participants' cell phone usage information. This application will also ask the participant several questions during the installation, during participation as well as at the end. Furthermore, the investigators will ask the participant about the dietary intake and habits.

    The aim is to learn how the 24-hour rhythm is connected to the social activity and behavior as well as blood pressure and metabolites as markers for the health status.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    6 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Exploratory Study in Healthy Volunteers to Define Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics
    Study Start Date :
    Sep 1, 2014
    Actual Primary Completion Date :
    Dec 1, 2017
    Actual Study Completion Date :
    Dec 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    Study group

    Healthy volunteers

    Outcome Measures

    Primary Outcome Measures

    1. Calls and Text Messages [3-4 months]

      Aggregate communication as behavioral features has been collected using the cell phone data streams.

    2. Changes Over Time in Ambulatory Blood Pressure - Systolic Blood Pressure [48 hours]

      Ambulatory blood pressure monitoring

    3. Percentage of Total Metabolites [48 hours]

      Percentage of metabolites displaying different abundances in biosamples collected during the morning hours versus evening hours. Analysis was performed for all participants as a group.

    4. Mobility Radius [3-4 months]

      The approximate radius of an imaginary circle encompassing the various locations that a user has traveled across on a particular day (in miles)

    5. Calls [3-4 months]

      Number of phone calls placed and received

    6. Changes Over Time in Ambulatory Blood Pressure - Diastolic Blood Pressure [48 hours]

      Ambulatory blood pressure monitoring

    7. Unanswered Calls [3-4 months]

      The number of calls unanswered.

    8. Unique Contacts [3-4 months]

      The total number of unique individuals with whom a participant interacted through phone calls or sms messages indicating interaction diversity

    9. Call Duration [3-4 months]

      The duration of calls (made + received)

    10. Text Message Length [3-4 months]

      The total length of all sms messages (sent + received) in characters

    11. Text Messages [3-4 months]

      The number of sms messages (sent + received)

    Secondary Outcome Measures

    1. Self-reported Sleep Times [Survey] [3-4 months]

      Cell phone administered survey where participants indicated start and end of sleep times. From this the total hours of sleep per night was calculated.

    2. Time Asleep [3-4 months]

      Hours asleep per each 24 hour period measured by actigraphy

    3. Physical Activity [3-4 months]

      Difference in locomotion between wake and sleep times

    4. Changes Over Time in Nutrient Intake - Energy [48 hours]

      Nutrient intake will be measured using food photography

    5. Changes Over Time in Ribonucleic Acids (RNA) - ARNTL (BMAL1) Normalized to GAPDH [48 hours]

    6. Genera Displaying Different Abundances Measured During Morning Versus Evening Hours in the Oral Microbiome [48 hours]

      Analysis was performed for all participants as a group.

    7. Proteins Displaying Different Abundances Measured in the Morning Versus Evening Hours [48 hours]

      Analysis was performed for all participants as a group.

    8. Changes Over Time in Kidney Function [48 hours]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Volunteers must be in good health as based on medical history, physical examination, vital signs, and laboratory tests as deemed by PI;

    • Volunteers are capable of giving informed consent;

    • 25-35 years of age;

    • Own a cell phone with internet access (smartphone with Android operating system only at this point) which installs the social sensing application ginger.io;

    • Non-smoking;

    • Male subjects only if feasible during recruitment; and

    • In case female volunteers are invited to enroll: non-pregnant, female subjects must consent to a urine pregnancy test.

    Exclusion Criteria:
    • Recent travel across time zones (within the past month);

    • Planned travel across time zones during the planned study activities;

    • Volunteers with irregular work hours, e.g. night shifts.

    • Use of illicit drugs;

    • Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening.

    • Subjects with any abnormal laboratory value or physical finding that according to the investigator may interfere with interpretation of the study results, be indicative of an underlying disease state, or compromise the safety of a potential subject.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • University of Pennsylvania
    • Ginger.io

    Investigators

    • Principal Investigator: Carsten Skarke, MD, University of Pennsylvania
    • Principal Investigator: Garret A FitzGerald, MD, University of Pennsylvania
    • Principal Investigator: Aalim Weljie, PhD, University of Pennsylvania

    Study Documents (Full-Text)

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Carsten Skarke, MD, Research Assistant Professor, University of Pennsylvania
    ClinicalTrials.gov Identifier:
    NCT02249793
    Other Study ID Numbers:
    • 817759
    First Posted:
    Sep 26, 2014
    Last Update Posted:
    Jan 18, 2020
    Last Verified:
    Jan 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Carsten Skarke, MD, Research Assistant Professor, University of Pennsylvania

    Study Results

    Participant Flow

    Recruitment Details Study Started 9/24/14, Ended 3/11/15 located at the Clinical and Translational Research Center, CTRC located at the University of Pennsylvania Hospital
    Pre-assignment Detail
    Arm/Group Title Session 1, 48-hour
    Arm/Group Description Healthy volunteers; The observation time for the biosensor-derived data was a total of four months with two 48-hour sessions (Session 1 & 2) scheduled two weeks apart to extend the biosensor platform by ambulatory blood pressure monitoring (ABPM) and timestamped dietary intake (SmartIntake) as well as by collection of timed biospecimens for multiomics analysis at 12-hour intervals.
    Period Title: Session 1, 48-hours Healthy Volunteers
    STARTED 6
    COMPLETED 6
    NOT COMPLETED 0
    Period Title: Session 1, 48-hours Healthy Volunteers
    STARTED 6
    COMPLETED 6
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Male Healthy Volunteers
    Arm/Group Description Males
    Overall Participants 6
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    6
    100%
    >=65 years
    0
    0%
    Sex: Female, Male (Count of Participants)
    Female
    0
    0%
    Male
    6
    100%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    0
    0%
    Not Hispanic or Latino
    6
    100%
    Unknown or Not Reported
    0
    0%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    Asian
    1
    16.7%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    Black or African American
    0
    0%
    White
    3
    50%
    More than one race
    2
    33.3%
    Unknown or Not Reported
    0
    0%

    Outcome Measures

    1. Primary Outcome
    Title Calls and Text Messages
    Description Aggregate communication as behavioral features has been collected using the cell phone data streams.
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    18.7
    Sleeping
    0.9
    2. Primary Outcome
    Title Changes Over Time in Ambulatory Blood Pressure - Systolic Blood Pressure
    Description Ambulatory blood pressure monitoring
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Difference Day versus Night
    20.7
    (3.9)
    Awake
    126.1
    (10.6)
    Asleep
    106.8
    (11.6)
    3. Primary Outcome
    Title Percentage of Total Metabolites
    Description Percentage of metabolites displaying different abundances in biosamples collected during the morning hours versus evening hours. Analysis was performed for all participants as a group.
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Plasma metabolome
    5.4
    Saliva metabolome
    5.6
    4. Primary Outcome
    Title Mobility Radius
    Description The approximate radius of an imaginary circle encompassing the various locations that a user has traveled across on a particular day (in miles)
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Mean (Full Range) [miles]
    6.8
    5. Primary Outcome
    Title Calls
    Description Number of phone calls placed and received
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    2.7
    Sleeping
    0.1
    6. Primary Outcome
    Title Changes Over Time in Ambulatory Blood Pressure - Diastolic Blood Pressure
    Description Ambulatory blood pressure monitoring
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Difference Day versus Night
    20.7
    (3.3)
    Awake
    78.5
    (9.1)
    Asleep
    58.8
    (10.2)
    7. Primary Outcome
    Title Unanswered Calls
    Description The number of calls unanswered.
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    0.6
    Sleeping
    0.03
    8. Primary Outcome
    Title Unique Contacts
    Description The total number of unique individuals with whom a participant interacted through phone calls or sms messages indicating interaction diversity
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    7.2
    Sleeping
    0.5
    9. Primary Outcome
    Title Call Duration
    Description The duration of calls (made + received)
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    820.4
    Sleeping
    22.0
    10. Primary Outcome
    Title Text Message Length
    Description The total length of all sms messages (sent + received) in characters
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    868.0
    Sleeping
    47.0
    11. Primary Outcome
    Title Text Messages
    Description The number of sms messages (sent + received)
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    16.0
    Sleeping
    0.8
    12. Secondary Outcome
    Title Self-reported Sleep Times [Survey]
    Description Cell phone administered survey where participants indicated start and end of sleep times. From this the total hours of sleep per night was calculated.
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Session 1, 48-hour
    Arm/Group Description Healthy volunteers; The observation time for the biosensor-derived data was a total of four months with two 48-hour sessions (Session 1 & 2) scheduled two weeks apart to extend the biosensor platform by ambulatory blood pressure monitoring (ABPM) and timestamped dietary intake (SmartIntake) as well as by collection of timed biospecimens for multiomics analysis at 12-hour intervals.
    Measure Participants 6
    Mean (Standard Deviation) [hour]
    7.6
    (2.9)
    13. Secondary Outcome
    Title Time Asleep
    Description Hours asleep per each 24 hour period measured by actigraphy
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Mean (Standard Deviation) [hours]
    7.931449224
    (0.7044404472)
    14. Secondary Outcome
    Title Physical Activity
    Description Difference in locomotion between wake and sleep times
    Time Frame 3-4 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Awake
    1904.0
    Sleeping
    307.2
    15. Secondary Outcome
    Title Changes Over Time in Nutrient Intake - Energy
    Description Nutrient intake will be measured using food photography
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Session 1
    1967
    (488)
    Session 2
    1609
    (601)
    16. Secondary Outcome
    Title Changes Over Time in Ribonucleic Acids (RNA) - ARNTL (BMAL1) Normalized to GAPDH
    Description
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Morning
    23.3
    (13.5)
    Evening
    17.9
    (9.4)
    17. Secondary Outcome
    Title Genera Displaying Different Abundances Measured During Morning Versus Evening Hours in the Oral Microbiome
    Description Analysis was performed for all participants as a group.
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Number [genera]
    3
    18. Secondary Outcome
    Title Proteins Displaying Different Abundances Measured in the Morning Versus Evening Hours
    Description Analysis was performed for all participants as a group.
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Study Group
    Arm/Group Description Healthy volunteers
    Measure Participants 6
    Number [Proteins]
    2
    19. Secondary Outcome
    Title Changes Over Time in Kidney Function
    Description
    Time Frame 48 hours

    Outcome Measure Data

    Analysis Population Description
    Kidney function was done to evaluate healthy volunteers during Session 1 and 2. Delta was calculated between Session 1 and 2 and averaged across subjects. Note that values for session1 was missing for two subjects, meaning that below reported mean and standard deviation reflect changes for four subjects.
    Arm/Group Title Session 1, 48-hour
    Arm/Group Description Healthy volunteers; The observation time for the biosensor-derived data was a total of four months with two 48-hour sessions (Session 1 & 2) scheduled two weeks apart to extend the biosensor platform by ambulatory blood pressure monitoring (ABPM) and timestamped dietary intake (SmartIntake) as well as by collection of timed biospecimens for multiomics analysis at 12-hour intervals.
    Measure Participants 6
    Mean (Standard Deviation) [mg/dL]
    12.925
    (115.468246)

    Adverse Events

    Time Frame 1 year
    Adverse Event Reporting Description All non serious AE were resolved, Serious AE: None
    Arm/Group Title Healthy Volunteers
    Arm/Group Description Males
    All Cause Mortality
    Healthy Volunteers
    Affected / at Risk (%) # Events
    Total 0/6 (0%)
    Serious Adverse Events
    Healthy Volunteers
    Affected / at Risk (%) # Events
    Total 0/6 (0%)
    Other (Not Including Serious) Adverse Events
    Healthy Volunteers
    Affected / at Risk (%) # Events
    Total 1/6 (16.7%)
    General disorders
    headache 1/6 (16.7%) 2

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Carsten Skarke
    Organization Upenn
    Phone 215-573-0673
    Email cskarke@pennmedicine.upenn.edu
    Responsible Party:
    Carsten Skarke, MD, Research Assistant Professor, University of Pennsylvania
    ClinicalTrials.gov Identifier:
    NCT02249793
    Other Study ID Numbers:
    • 817759
    First Posted:
    Sep 26, 2014
    Last Update Posted:
    Jan 18, 2020
    Last Verified:
    Jan 1, 2020